Masitinib in Locally Advanced/Metastatic Gastro-intestinal Stromal Tumour (GIST)
NCT00998751
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
30
Enrollment
INDUSTRY
Sponsor class
Conditions
Gastro-intestinal Stromal Tumours
Interventions
DRUG:
oral masitinib
Sponsor
AB Science